EXAS · As filed with the SEC

Exact Sciences balance sheet, by quarter

The statement as Exact Sciences presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousands	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025
ASSETS
Current assets:
Cash and cash equivalents	955,996	789,037	657,099	347,127
Marketable securities	8,715	214,058	201,336	439,048
Accounts receivable, net	298,653	306,051	353,335	279,800
Inventory	166,201	164,784	171,499	176,574
Prepaid expenses and other current assets	126,284	116,796	124,590	127,792
Total current assets	1,555,849	1,590,726	1,507,859	1,370,341
Long-term assets:
Property, plant and equipment, net	708,664	704,065	705,105	697,907
Operating lease right-of-use assets	122,332	121,114	126,106	126,659
Goodwill	2,368,048	2,368,028	2,368,021	2,367,111
Intangible assets, net	919,925	941,200	965,370	988,873
Other long-term assets, net	185,811	174,876	124,904	160,182
Total assets	5,860,629	5,900,009	5,797,365	5,711,073
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	175,868	129,356	157,324	142,175
Accrued liabilities	416,473	408,774	317,154	295,137
Operating lease liabilities, current portion	33,591	31,851	31,338	29,808
Other current liabilities	15,220	14,279	16,117	35,345
Convertible Notes Payable, Current	0	0	0	0
Total current liabilities	641,152	584,260	521,933	502,465
Convertible notes, net, less current portion	2,327,177	2,325,637	2,324,097	2,322,574
Other long-term liabilities	329,317	324,807	315,899	320,225
Operating lease liabilities, less current portion	161,931	163,886	166,022	168,902
Total liabilities	3,459,577	3,398,590	3,327,951	3,314,166
Stockholders’ equity:
Preferred stock, $0.01 par value Authorized—5,000,000 shares issued and outstanding—no shares at December 31, 2025 and December 31, 2024	0	0	0	0
Common stock, $0.01 par value Authorized—400,000,000 shares issued and outstanding—190,802,322 and 185,616,438 shares at December 31, 2025 and December 31, 2024	1,909	1,896	1,893	1,887
Additional paid-in capital	7,102,766	7,116,306	7,064,867	6,993,254
Accumulated other comprehensive income (loss)	2,358	3,243	3,086	1,013
Accumulated deficit	(4,705,981)	(4,620,026)	(4,600,432)	(4,599,247)
Total stockholders’ equity	2,401,052	2,501,419	2,469,414	2,396,907
Total liabilities and stockholders’ equity	5,860,629	5,900,009	5,797,365	5,711,073

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.